Cardiovascular
Health
VO₂ max is the single strongest predictor of longevity — surpassing smoking status, hypertension, and metabolic syndrome as a mortality risk factor. This hub covers zone-2 training, HRV, and cardiovascular biomarkers that actually matter.
Landmark Research
The Science of Cardiovascular Longevity
The studies that established cardiorespiratory fitness as a primary longevity biomarker.
VO₂ Max and Mortality — The Strongest Modifiable Risk Factor
In 122,007 patients followed for a median of 8.4 years, individuals with the highest VO₂ max had a 5× lower mortality risk than those with the lowest fitness. The hazard ratio from elite fitness to low fitness exceeded smoking.
PMID 30566503 ↗Zone 2 Training and Mitochondrial Biogenesis
Low-intensity steady-state cardio (65–75% HRmax) is the most potent stimulus for PGC-1α activation and mitochondrial biogenesis — the cellular mechanism underlying endurance adaptation and metabolic health improvement.
PMID 20136682 ↗Heart Rate Variability (HRV) as Recovery and Health Marker
Higher resting HRV is consistently associated with lower cardiovascular mortality, better autonomic nervous system function, and superior exercise recovery. HRV reflects parasympathetic tone and is one of the most informative daily health signals available from wearables.
PMID 29034226 ↗HIIT vs Zone 2 — Complementary, Not Competing
High-intensity interval training (HIIT) produces comparable VO₂ max improvements to continuous moderate-intensity training in less time, but zone 2 is superior for mitochondrial density and fat oxidation capacity. Optimal longevity protocol combines both.
PMID 25771883 ↗Omega-3 and Cardiovascular Mortality
Meta-analysis of 13 RCTs (n=127,477): marine omega-3 supplementation was associated with a 10% reduction in cardiovascular mortality and 8% reduction in fatal MI. EPA:DHA ratio and dose (>1g/day EPA+DHA) matter significantly for effect size.
PMID 31567003 ↗Resting Heart Rate Decline as VO₂ Max Proxy
Each 10 bpm reduction in resting heart rate is associated with ~20% lower cardiovascular mortality in prospective cohort data. Resting HR can serve as a free, real-time cardiovascular fitness proxy between formal VO₂ max assessments.
PMID 22896693 ↗Training Zones
Heart Rate Training Zones Explained
Based on percentage of maximum heart rate. Use the HR Zone Calculator to get your personalized targets.
| Zone | % Max HR | Feel | Primary Fuel | Longevity Benefit |
|---|---|---|---|---|
| Zone 1 | 50–60% | Very easy — active recovery | Fat | Recovery, base aerobic capacity |
| Zone 2 | 60–70% | Conversational — you can talk in full sentences | Fat (peak fat oxidation) | Mitochondrial biogenesis, fat metabolism, longevity sweet spot |
| Zone 3 | 70–80% | Moderate — full sentences become difficult | Mixed fat/carb | Aerobic power, lactate clearance |
| Zone 4 | 80–90% | Hard — only short phrases possible | Carbohydrate | VO₂ max improvement, lactate threshold |
| Zone 5 | 90–100% | All-out — unsustainable beyond ~3 minutes | Carbohydrate (anaerobic) | Peak VO₂ max, neuromuscular recruitment |
Optimal longevity protocol (per Peter Attia / Iñigo San Millán): 80% of weekly cardio in Zone 2, 20% in Zone 4–5 (HIIT). Minimum 150–180 min/week zone 2 for mitochondrial adaptation.
Editor's Picks
Cardiovascular Health Supplements
Compounds with peer-reviewed cardiovascular evidence — not marketing claims.
Nordic Naturals Ultimate Omega
2,840mg omega-3/serving (1,680mg EPA + 560mg DHA) in natural triglyceride form — superior bioavailability vs ethyl ester forms. Friend of the Heart certified.
View on Amazon →Qunol Mega CoQ10 Ubiquinol
100mg ubiquinol — the active, reduced form of CoQ10 with up to 8× higher bioavailability than standard ubiquinone. Essential for cardiac energy production; levels decline 65% by age 80.
View on Amazon →Doctor's Best High Absorption Magnesium
200mg elemental magnesium as magnesium glycinate/lysinate chelate — the most bioavailable form. Magnesium deficiency is associated with 24% higher cardiovascular event risk in prospective data.
View on Amazon →Common Questions
FAQ
What VO₂ max should I aim for at my age?
VO₂ max declines ~1% per year after age 25 without training. For longevity purposes, the goal is to stay in the "superior" or "elite" category for your age bracket. As a rough benchmark: men aged 40–49 should target ≥48 ml/kg/min ("superior"), and women ≥37 ml/kg/min. Elite ranges are >56 (men 40–49) and >46 (women 40–49). Use our VO₂ Max Calculator to estimate your current level from heart rate data.
How much zone 2 training per week for longevity?
Based on current evidence (particularly the work of Iñigo San Millán and Peter Attia), a minimum of 150–180 minutes of true zone 2 per week appears necessary for meaningful mitochondrial adaptation. Elite endurance athletes do 8–12 hours/week, with 80% in zone 2. For longevity-focused training, 3–4 hours/week of zone 2 combined with 1–2 HIIT sessions appears to produce the best outcomes. Zone 2 should feel genuinely easy — if you can't hold a full conversation, you're not in zone 2.
What is HRV and why does it matter?
Heart rate variability is the variation in time between consecutive heartbeats. A higher HRV indicates greater parasympathetic (rest-and-digest) dominance and better autonomic nervous system function. Low HRV is associated with cardiovascular disease, poor recovery, overtraining, chronic stress, and higher all-cause mortality. HRV is now tracked by Oura Ring, WHOOP, Apple Watch, and Garmin — though measurement accuracy varies. Your personal trend over time matters more than any single absolute number.
Does running damage your heart in the long run?
The evidence does not support the "too much exercise is harmful" narrative for recreational athletes. The J-curve hypothesis (based on marathon studies) appears to reflect an extremely high dose — well beyond what recreational runners achieve. For the vast majority of people, more aerobic exercise volume is associated with lower cardiovascular mortality with no upper threshold visible in population data. Elite-level coronary artery calcium (CAC) accumulation is real but appears non-obstructive in athletes and does not translate to elevated mortality risk.